Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare... see more

NDAQ:INM - Post Discussion

InMed Pharmaceuticals Inc > Absolute joke!!
View:
Post by gainwidpatience on Feb 05, 2021 9:51am

Absolute joke!!

Just a week back, Eric had said there is sufficient cash during that interview!! and now they announce a PP. Obviously, it explains why the stock was brought down yday!
Comment by Stevemin on Feb 05, 2021 11:55am
The IPO price was $4.50 and today (2 1/2 months later) they raise more money at $4.25 (5.5% lower).... Adams is making it clear that he sees no appreciable raise in sp in the near future. I'm no fan of Adams, but even this news today surprised me. I didn't think even HE had the nerve to smack investors in the face again. We can only assume that Integrasyn is nowhere near as close to ...more  
Comment by Bullknit101 on Feb 05, 2021 6:24pm
Almost every Cannabis and related company raised capital in the last few weeks so not surprised with this at all. The GW deal will continue to shed light on cannabinoid biotechs. Todd Harrison mentioned INM a few times in the week alone. Let's see what's around the corner.
Comment by Stevemin on Feb 05, 2021 7:21pm
It absolutley boggles my mind that anyone would be ok with todays private placement. - Inmed was not in a pinch for cash - they just raised $8M in Nov. - The sp literally closed at $4.19 four days ago - how is this capitalizing on price appreciation? - How does this justify an immediate 15% dilution (and further dilution when warrants are         exercised) - If ...more  
Comment by AllIn416 on Feb 06, 2021 9:43pm
I didn't see any mention of INM by todd harrison this week..can you provide further details?
Comment by Bullknit101 on Feb 07, 2021 9:39am
You have to scroll through Todd Harrison Twitter feeds after the Jazz GW Pharma news. He included tickers $INM as well as other like Cardiol Thera, Tetra Bio etc... So leaves me to believe he still has a position. Btw I didnt like the Friday night news release, Friday night's for hidding. On another note, some tech analysis I came across (some podcast stock talk on twitter) showed that if we ...more  
Comment by gainwidpatience on Feb 07, 2021 7:18pm
I sold all my shares on US account.. still holding 50% on CAD side. This is what efficient CEO's do unlike Eric who announces pp at lower price when there is bullish momentum!  https://www.google.ca/amp/s/www.paidpromotionalmessages.com/companies/amp/news/940556
Comment by gainwidpatience on Feb 07, 2021 8:13pm
Sorry.. this is the link I was referring to: https://www.paidpromotionalmessages.com/companies/news/940556/willow-biosciences-is-set-to-benefit-from-jazz-pharmaceuticals-acquisition-of-gw-pharmaceuticals-940556.html
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities